StockWatch
·

COLGATE-PALMOLIVE (INDIA) LTD.

BSE: 500830

P/L Snapshot

Q2 FY27 · standalone

vs Q1 FY27·vs Q2 FY26
Revenue
1.7K
+6.2%+12.6%
Expenditure
1.3K
+9.2%+16.0%
Net Profit
341.57
-0.4%+4.3%
OPM %
27.76%
-2.16pp-2.87pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.00483.70967.401.5K1.9KQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Price Chart
Reports

Colgate Q2 FY27: revenue +12% YoY, PAT +4% as A&P jumps 40%, margins compress ~290bps

fmcg · oral care · margin compression

ResultsQ2 FY2722 Oct 20263 minFMCG

Premium momentum carries into Q2—can Street's 10% growth thesis hold post-leadership handoff?

premiumization · double-digit growth · margin resilience

Result previewQ2 FY2716 Oct 20263 minFMCG

Premium Flywheel Spins, but Credibility Cracks Under Sequential Weakness

premiumisation · margin discrepancy · QoQ weakness

Result verdictFollow-upQ1 FY2721 Aug 20266 minFMCG
Latest
Board Meeting22 Oct, 4:30 pm

Colgate Q2 FY27: revenue +12% YoY, PAT +4% as A&P jumps 40%, margins compress ~290bps

Colgate-Palmolive India's standalone Q2 FY27 (quarter ended September 30, 2026) revenue from operations came in at ₹1,705.79 Cr, up 12.3% YoY and 6.4% QoQ — a second straight quarter of double-digit top-line growth after Q1 FY27's 11.8%. But profit growth badly lagged: PAT of ₹341.57 Cr (EPS ₹12.56) rose just 4.3% YoY and actually slipped 0.4% QoQ from ₹343.08 Cr, with no exceptional items in either the current or year-ago quarter to distort the comparison — this is a genuine, operating-level growth-to-profit gap, not a base-effect or one-off artifact. The gap sits squarely in margins: net profit margin fell to 19.8% of total income from 21.3% a year ago and 21.1% last quarter (a ~150bps YoY compression), while operating margin (EBITDA/revenue-from-operations) eased to roughly 27.8% from ~30.6% YoY and ~29.9% QoQ. The driver is advertising: A&P spend jumped 39.9% YoY and 25.0% QoQ to ₹314.82 Cr, taking A&P intensity to ~18.5% of revenue — above the ~15.8% level (up from 12-13%) management flagged on the August 2026 concall as the new normal for absorbing premiumisation-led brand investment. Employee costs also rose a faster 15.1% YoY, adding to the squeeze, while cost of materials grew a more moderate 9.2% YoY. Against management's own prior guidance — sustained double-digit growth via volume/price/mix, margins absorbing higher A&P — this quarter is a clean match: growth delivered, and A&P ran even hotter than the 15.8% marker, so the compression reflects the plan playing out rather than a miss. No formal numeric consensus for this specific quarter turned up in public previews, so vsStreet is marked unknown; the broader brokerage tone (Goldman Sachs and Citi have held Sell ratings through 2026) has flagged exactly these margin and competitive-intensity concerns. It's also worth noting the YoY base is soft: Q2 FY26 PAT itself had fallen 17.1% YoY on GST-transition distributor disruption, so this year's +4.3% YoY sits on a depressed prior-year print. Alongside the results, the board declared a first interim dividend of ₹24/share (₹652.77 Cr aggregate, record date November 2, 2026), and separately the company saw a marketing leadership change — EVP-Marketing Gunjit Jain resigns effective November 30, succeeded by Akash Parekh from December 1 — landing just as A&P investment is being stepped up. No standalone press-release commentary from management was available in the filing to cross-check against the numbers. The quarter sets up two things to track: whether the ~18.5% A&P intensity holds or normalizes toward the guided 15.8% band in H2 FY27, and whether double-digit revenue growth is durable as the GST-disruption base effect fades through Q3-Q4 FY27. The company has no subsidiary or joint venture, so no consolidated statement is filed, and with a single reportable segment there's no sub-segment data to corroborate the volume/price/mix split underlying the growth.

22 Oct 2026, 04:30 pm

Corporate Events

DividendCOLPAL
2026
2Nov

₹24 / share

BSE Filing ↗
Board MeetingCOLPAL
2026
22Oct

Board Meeting

The meeting of the Board of Directors will be held to approv…

BSE Filing ↗
Board MeetingCOLPAL
2026
28Sep

Board Meeting

The Board of Directors noted the resignation of Mr. Priyan …

BSE Filing ↗
Board MeetingCOLPAL
2026
21Aug

Board Meeting

The Board of Directors noted the resignation of Ms. Prabha …

BSE Filing ↗
Board MeetingCOLPAL
2026
29Jul

Board Meeting

The company has scheduled its 85th Annual General Meeting. …

BSE Filing ↗
Board MeetingCOLPAL
2026
29Jul

Board Meeting

The company has scheduled its 85th Annual General Meeting ("…

BSE Filing ↗
DividendCOLPAL
2026
1Jun

₹24 / share

BSE Filing ↗
Board MeetingCOLPAL
2024
24Oct

Board Meeting

Consider and approve the Unaudited Financial Results for the…

BSE Filing ↗
Board MeetingCOLPAL
2024
29Jul

Board Meeting

Consider and approve Unaudited Financial Results for the qua…

BSE Filing ↗
DividendCOLPAL
2024
23May

₹26 / share

BSE Filing ↗
Board MeetingCOLPAL
2024
22Jan

Board Meeting

Consider and approve Intimation under Regulation 29 of SEBI …

BSE Filing ↗
DividendCOLPAL
2023
6Nov

₹22 / share

BSE Filing ↗
Board MeetingCOLPAL
2023
26Oct

Board Meeting

Approve and take on record the Unaudited Financial Results f…

BSE Filing ↗